Source: Pharamceutical Technology

Replay: JURA Bio and Syena partner to develop TCR-based therapies

JURA Bio has entered into a research collaboration with Replay cell therapy product company Syena for the development of TCR based therapies.

Read full article »
Replay's Competitors | Replay's News | Replay's Financials
Stay up-to-date with the latest news on Replay
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Lachlan MacKinnon's photo - Co-Founder & CEO of Replay

Co-Founder & CEO

Lachlan MacKinnon

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Replay